The global Antivenom revenue was US$ 959.2 million in 2022 and is forecast to a readjusted size of US$ 1283.7 million by 2029 with a CAGR of 4.2% during the forecast period (2023-2029).

and India Antivenom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

In India, the Antivenom revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

This report focuses on global and India Antivenom market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Antivenom will continue to grow rapidly in the future.

Global Antivenom Scope and Market Size

Antivenom market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Antivenom market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Antivenom Market Report

Report Metric	Details
Report Name	and India Antivenom Market
Forecasted market size in 2029	US$ 1283.7 million
CAGR	4.2%
Forecasted years	2023 - 2029
Segment by Type	Polyvalent antivenom Monovalent antivenom
Segment by Application	Non-profit Institutions Hospitals and Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Antivenom Market size in 2029?

Ans: The and India Antivenom Market size in 2029 will be US$ 1283.7 million.

What is the CSL, Merck, BTG, Pfizer, Haffkine Bio Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm share in and India Antivenom Market?

Ans: CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm.

What is the and India Antivenom Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Antivenom Market report?

Ans: The main players in the and India Antivenom Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm

What are the Application segmentation covered in the and India Antivenom Market report?

Ans: The Applications covered in the and India Antivenom Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the and India Antivenom Market report?

Ans: The Types covered in the and India Antivenom Market report are Polyvalent antivenom, Monovalent antivenom

1 Study Coverage

1.1 Antivenom Product Introduction

1.2 Global Antivenom Outlook 2018 VS 2022 VS 2029

1.2.1 Global Antivenom Sales in US$ Million for the Year 2018-2029

1.2.2 Global Antivenom Sales in Volume for the Year 2018-2029

1.3 India Antivenom Outlook 2018 VS 2022 VS 2029

1.3.1 India Antivenom Sales in US$ Million for the Year 2018-2029

1.3.2 India Antivenom Sales in Volume for the Year 2018-2029

1.4 Antivenom Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Antivenom in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Antivenom Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Antivenom Market Dynamics

1.5.1 Antivenom Industry Trends

1.5.2 Antivenom Market Drivers

1.5.3 Antivenom Market Challenges

1.5.4 Antivenom Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Antivenom by Type

2.1 Antivenom Market Segment by Type

2.1.1 Polyvalent antivenom

2.1.2 Monovalent antivenom

2.2 Global Antivenom Market Size by Type

2.2.1 Global Antivenom Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Antivenom Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Antivenom Market Size by Type

2.3.1 India Antivenom Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Antivenom Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Antivenom by Application

3.1 Antivenom Market Segment by Application

3.1.1 Non-profit Institutions

3.1.2 Hospitals and Clinic

3.2 Global Antivenom Market Size by Application

3.2.1 Global Antivenom Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Antivenom Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Antivenom Market Size by Application

3.3.1 India Antivenom Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Antivenom Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Antivenom Competitor Landscape by Company

4.1 Global Antivenom Market Size by Company

4.1.1 Global Key Manufacturers of Antivenom, Ranked by Revenue (2022)

4.1.2 Global Antivenom Revenue by Manufacturer (2018-2023)

4.1.3 Global Antivenom Sales by Manufacturer (2018-2023)

4.1.4 Global Antivenom Price by Manufacturer (2018-2023)

4.2 Global Antivenom Concentration Ratio (CR)

4.2.1 Antivenom Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antivenom in 2022

4.2.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Antivenom, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Antivenom, Product Offered and Application

4.5 Global Key Manufacturers of Antivenom, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Antivenom Market Size by Company

4.7.1 Key Players of Antivenom in India, Ranked by Revenue (2022)

4.7.2 India Antivenom Revenue by Players (2018-2023)

4.7.3 India Antivenom Sales by Players (2018-2023)

5 Global Antivenom Market Size by Region

5.1 Global Antivenom Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Antivenom Market Size in Volume by Region (2018-2029)

5.2.1 Global Antivenom Sales in Volume by Region: 2018-2023

5.2.2 Global Antivenom Sales in Volume Forecast by Region (2024-2029)

5.3 Global Antivenom Market Size in Value by Region (2018-2029)

5.3.1 Global Antivenom Sales in Value by Region: 2018-2023

5.3.2 Global Antivenom Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Antivenom Market Size YoY Growth 2018-2029

6.2 Americas Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Antivenom Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Antivenom Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Antivenom Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Antivenom Market Size YoY Growth 2018-2029

7.2 EMEA Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Antivenom Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Antivenom Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Antivenom Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Antivenom Market Size YoY Growth 2018-2029

8.2 China Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Antivenom Market Size YoY Growth 2018-2029

9.2 APAC Antivenom Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Antivenom Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Antivenom Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Antivenom Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Antivenom Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 CSL

10.1.1 CSL Company Information

10.1.2 CSL Description and Business Overview

10.1.3 CSL Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.1.4 CSL Antivenom Products Offered

10.1.5 CSL Recent Development

10.2 Merck

10.2.1 Merck Company Information

10.2.2 Merck Description and Business Overview

10.2.3 Merck Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Merck Antivenom Products Offered

10.2.5 Merck Recent Development

10.3 BTG

10.3.1 BTG Company Information

10.3.2 BTG Description and Business Overview

10.3.3 BTG Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.3.4 BTG Antivenom Products Offered

10.3.5 BTG Recent Development

10.4 Pfizer

10.4.1 Pfizer Company Information

10.4.2 Pfizer Description and Business Overview

10.4.3 Pfizer Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Pfizer Antivenom Products Offered

10.4.5 Pfizer Recent Development

10.5 Haffkine Bio-Pharmaceutical

10.5.1 Haffkine Bio-Pharmaceutical Company Information

10.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview

10.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Haffkine Bio-Pharmaceutical Antivenom Products Offered

10.5.5 Haffkine Bio-Pharmaceutical Recent Development

10.6 Rare Disease Therapeutics

10.6.1 Rare Disease Therapeutics Company Information

10.6.2 Rare Disease Therapeutics Description and Business Overview

10.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Rare Disease Therapeutics Antivenom Products Offered

10.6.5 Rare Disease Therapeutics Recent Development

10.7 Flynn Pharma

10.7.1 Flynn Pharma Company Information

10.7.2 Flynn Pharma Description and Business Overview

10.7.3 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Flynn Pharma Antivenom Products Offered

10.7.5 Flynn Pharma Recent Development

10.8 Vins Bioproducts

10.8.1 Vins Bioproducts Company Information

10.8.2 Vins Bioproducts Description and Business Overview

10.8.3 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Vins Bioproducts Antivenom Products Offered

10.8.5 Vins Bioproducts Recent Development

10.9 Bharat Serums and Vaccines

10.9.1 Bharat Serums and Vaccines Company Information

10.9.2 Bharat Serums and Vaccines Description and Business Overview

10.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Bharat Serums and Vaccines Antivenom Products Offered

10.9.5 Bharat Serums and Vaccines Recent Development

10.10 Serum Biotech

10.10.1 Serum Biotech Company Information

10.10.2 Serum Biotech Description and Business Overview

10.10.3 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Serum Biotech Antivenom Products Offered

10.10.5 Serum Biotech Recent Development

10.11 MicroPharm

10.11.1 MicroPharm Company Information

10.11.2 MicroPharm Description and Business Overview

10.11.3 MicroPharm Antivenom Sales, Revenue and Gross Margin (2018-2023)

10.11.4 MicroPharm Antivenom Products Offered

10.11.5 MicroPharm Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Antivenom Industry Chain Analysis

11.2 Antivenom Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Antivenom Production Mode & Process

11.4 Antivenom Sales and Marketing

11.4.1 Antivenom Sales Channels

11.4.2 Antivenom Distributors

11.5 Antivenom Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Haffkine Bio Pharmaceutical

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

MicroPharm

List of Tables

Table 1. Antivenom CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Antivenom Market Trends

Table 3. Antivenom Market Drivers

Table 4. Antivenom Market Challenges

Table 5. Antivenom Market Restraints

Table 6. Global Antivenom Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Antivenom Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Antivenom Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Antivenom Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Antivenom, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Antivenom Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Antivenom Revenue Share by Manufacturer, 2018-2023

Table 13. Global Antivenom Sales by Manufacturer, (K Vials), 2018-2023

Table 14. Global Antivenom Sales Share by Manufacturer, 2018-2023

Table 15. Global Antivenom Price by Manufacturer (2018-2023) & (USD/Vial)

Table 16. Global Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenom as of 2022)

Table 18. Global Key Manufacturers of Antivenom, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Antivenom, Product Offered and Application

Table 20. Global Key Manufacturers of Antivenom, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Antivenom in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Antivenom Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Antivenom Revenue Share by Players, (2018-2023)

Table 25. India Antivenom Sales by Players, (K Vials), (2018-2023)

Table 26. India Antivenom Sales Share by Players, (2018-2023)

Table 27. Global Antivenom Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Antivenom Sales in Volume by Region (2018-2023) & (K Vials)

Table 29. Global Antivenom Sales in Volume Forecast by Region (2024-2029) & (K Vials)

Table 30. Global Antivenom Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Antivenom Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Antivenom Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Antivenom Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Antivenom Sales in Volume by Country (2018-2023) & (K Vials)

Table 36. Americas Antivenom Sales in Volume by Country (2024-2029) & (K Vials)

Table 37. EMEA Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Antivenom Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Antivenom Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Antivenom Sales in Volume by Country (2018-2023) & (K Vials)

Table 41. EMEA Antivenom Sales in Volume by Country (2024-2029) & (K Vials)

Table 42. APAC Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Antivenom Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Antivenom Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Antivenom Sales in Volume by Country (2018-2023) & (K Vials)

Table 46. APAC Antivenom Sales in Volume by Country (2024-2029) & (K Vials)

Table 47. CSL Company Information

Table 48. CSL Description and Business Overview

Table 49. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 50. CSL Antivenom Product

Table 51. CSL Recent Development

Table 52. Merck Company Information

Table 53. Merck Description and Business Overview

Table 54. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 55. Merck Antivenom Product

Table 56. Merck Recent Development

Table 57. BTG Company Information

Table 58. BTG Description and Business Overview

Table 59. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 60. BTG Antivenom Product

Table 61. BTG Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Description and Business Overview

Table 64. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 65. Pfizer Antivenom Product

Table 66. Pfizer Recent Development

Table 67. Haffkine Bio-Pharmaceutical Company Information

Table 68. Haffkine Bio-Pharmaceutical Description and Business Overview

Table 69. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 70. Haffkine Bio-Pharmaceutical Antivenom Product

Table 71. Haffkine Bio-Pharmaceutical Recent Development

Table 72. Rare Disease Therapeutics Company Information

Table 73. Rare Disease Therapeutics Description and Business Overview

Table 74. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 75. Rare Disease Therapeutics Antivenom Product

Table 76. Rare Disease Therapeutics Recent Development

Table 77. Flynn Pharma Company Information

Table 78. Flynn Pharma Description and Business Overview

Table 79. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 80. Flynn Pharma Antivenom Product

Table 81. Flynn Pharma Recent Development

Table 82. Vins Bioproducts Company Information

Table 83. Vins Bioproducts Description and Business Overview

Table 84. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 85. Vins Bioproducts Antivenom Product

Table 86. Vins Bioproducts Recent Development

Table 87. Bharat Serums and Vaccines Company Information

Table 88. Bharat Serums and Vaccines Description and Business Overview

Table 89. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 90. Bharat Serums and Vaccines Antivenom Product

Table 91. Bharat Serums and Vaccines Recent Development

Table 92. Serum Biotech Company Information

Table 93. Serum Biotech Description and Business Overview

Table 94. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 95. Serum Biotech Antivenom Product

Table 96. Serum Biotech Recent Development

Table 97. MicroPharm Company Information

Table 98. MicroPharm Description and Business Overview

Table 99. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 100. MicroPharm Antivenom Product

Table 101. MicroPharm Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Antivenom Customers List

Table 105. Antivenom Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Antivenom Product Picture

Figure 2. Global Antivenom Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Antivenom Market Size 2018-2029 (US$ Million)

Figure 4. Global Antivenom Sales 2018-2029 (K Vials)

Figure 5. India Antivenom Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Antivenom Market Size 2018-2029 (US$ Million)

Figure 7. India Antivenom Sales 2018-2029 (K Vials)

Figure 8. India Antivenom Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Antivenom Market Share in Global, in Volume (K Vials) 2018-2029

Figure 10. Antivenom Report Years Considered

Figure 11. Product Picture of Polyvalent antivenom

Figure 12. Product Picture of Monovalent antivenom

Figure 13. Global Antivenom Market Share by Type in 2022 & 2029

Figure 14. Global Antivenom Sales in Value by Type (2018-2029) & (US$ Million)

Figure 15. Global Antivenom Sales Market Share in Value by Type (2018-2029)

Figure 16. Global Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 17. Global Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 18. Global Antivenom Price by Type (2018-2029) & (USD/Vial)

Figure 19. India Antivenom Market Share by Type in 2022 & 2029

Figure 20. India Antivenom Sales in Value by Type (2018-2029) & (US$ Million)

Figure 21. India Antivenom Sales Market Share in Value by Type (2018-2029)

Figure 22. India Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 23. India Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 24. India Antivenom Price by Type (2018-2029) & (USD/Vial)

Figure 25. Product Picture of Non-profit Institutions

Figure 26. Product Picture of Hospitals and Clinic

Figure 27. Global Antivenom Market Share by Application in 2022 & 2029

Figure 28. Global Antivenom Sales in Value by Application (2018-2029) & (US$ Million)

Figure 29. Global Antivenom Sales Market Share in Value by Application (2018-2029)

Figure 30. Global Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 31. Global Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 32. Global Antivenom Price by Application (2018-2029) & (USD/Vial)

Figure 33. India Antivenom Market Share by Application in 2022 & 2029

Figure 34. India Antivenom Sales in Value by Application (2018-2029) & (US$ Million)

Figure 35. India Antivenom Sales Market Share in Value by Application (2018-2029)

Figure 36. India Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 37. India Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 38. India Antivenom Price by Application (2018-2029) & (USD/Vial)

Figure 39. Americas Antivenom Sales in Volume Growth Rate 2018-2029 (K Vials)

Figure 40. Americas Antivenom Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 41. Americas Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 42. Americas Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 43. Americas Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 44. Americas Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 45. United States Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 46. Canada Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Mexico Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Brazil Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. EMEA Antivenom Sales in Volume Growth Rate 2018-2029 (K Vials)

Figure 50. EMEA Antivenom Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 51. EMEA Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 52. EMEA Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 53. EMEA Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 54. EMEA Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 55. Europe Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 56. Middle East Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Africa Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. China Antivenom Sales in Volume Growth Rate 2018-2029 (K Vials)

Figure 59. China Antivenom Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 60. China Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 61. China Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 62. China Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 63. China Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 64. APAC Antivenom Sales in Volume Growth Rate 2018-2029 (K Vials)

Figure 65. APAC Antivenom Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 66. APAC Antivenom Sales by Type (2018-2029) & (K Vials)

Figure 67. APAC Antivenom Sales Market Share in Volume by Type (2018-2029)

Figure 68. APAC Antivenom Sales by Application (2018-2029) & (K Vials)

Figure 69. APAC Antivenom Sales Market Share in Volume by Application (2018-2029)

Figure 70. Japan Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 71. South Korea Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. China Taiwan Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. Southeast Asia Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. India Antivenom Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. Antivenom Value Chain

Figure 76. Antivenom Production Process

Figure 77. Channels of Distribution

Figure 78. Distributors Profiles

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global and India Antivenom Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-26W15533

Global and India Antivenom Market Report & Forecast 2023-2029

FEATURED COMPANIES

and India Antivenom Market Size

and India Antivenom Market

Scope of and India Antivenom Market Report

FAQ for this report

What is the and India Antivenom Market size in 2029?

What is the CSL, Merck, BTG, Pfizer, Haffkine Bio Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm share in and India Antivenom Market?

What is the and India Antivenom Market share by region?

Who are the main players in the and India Antivenom Market report?

What are the Application segmentation covered in the and India Antivenom Market report?

What are the Type segmentation covered in the and India Antivenom Market report?

FEATURED COMPANIES

RELATED REPORTS